Rupert Lowe is a former chairman of Southampton Leisure Holdings Limited and WH Ireland. He is also a member of the Committee who created the FTSE 100 Index. He has been Chairman/Director of Jubilee (Lloyds Insurance) since 2002 and he also formerly worked in the Morgan Grenfell Treasury.
Dr Michael von Bertele was the Director General of the Army Medical Services until 2012 and then worked for two years as the International Humanitarian Director for Save the Children International, including leading their response to the Ebola crisis in West Africa in 2014. He was appointed OBE in 1994, Honorary Surgeon to Her Majesty The Queen in 2008 and CB in 2012.
Professor Sir Chris Evans has a proven track record of establishing high-quality science companies, 20 of which have been taken public. He is widely regarded as Europe’s leading biotechnology entrepreneur and was appointed OBE in 1995 and Knighted in the New Year’s Honours List in 2001.
Nathan Irwin FCA is a non-executive director of Proton Partners International Ltd and Chairs the Audit Committee. Nathan's priary executive role is Western Provident Associations's Chief Financial Officer. Prior to joining WPA, Nathan worked as a director at PwC.
With over 15 years experience in building long-term investment objectives to maintain and grow investors wealth, Alain Baron joined Mirabaud Bank in 2012 and is currently serving as Managing Director. He has aligned interest between family businesses through creating a mutual investment philosophy.
Mike Moran MBE is a founder of the company and has 30 years of experience in strategic leadership, planning and programme delivery. He has held various executive positions in defence and healthcare in the UK and abroad and is the Former Chairman of the Chamber of Commerce & Learning & Skills Council in Hereford and Worcestershire.
Professor Karol Sikora is a founder of the company and has more than forty years of experience as an oncologist treating patients worldwide. He is the Former Chief of the World Health Organisation’s Cancer Programme and is the founding team member and Clinical Director of Cancer Partners UK.
With over 20 years’ experience of finance roles predominantly with “TMT” companies, Paul Tuson has been group finance director or chief financial officer with four AIM-liste UK plcs. He has led successful flotations, secondary fundraisings and successful venture capital exits.